# Context Therapeutics Inc.: Form 8-K, filed Aug 2, 2022

- Company: [Context Therapeutics Inc.](/companies/cntx.md) (CIK 1842952)
- Form: 8-K
- Filed: 2022-08-02
- Accepted by EDGAR: Aug 2, 2022, 07:31 ET
- Period: 2022-08-01
- Accession: 0001842952-22-000066
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1842952/000184295222000066/cntx-20220801.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1842952/000184295222000066/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1842952/000184295222000066/cntx-20220801.htm

Filed Aug 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001842952-22-000066. Last ingested by Listed: Nov 11, 2026, 01:22 ET. No prices; not investment advice.
